Analysis of R213R and 13494 g→a polymorphisms of the p53 gene in individuals with esophagitis, intestinal metaplasia of the cardia and Barrett's Esophagus compared with a control group

Genomic Medicine

Volumn 1, Issue 1-2, 2007, Pages 57-63

  Pilger, Diogo André ^a   Da Costa Lopez, Patrícia Luciana ^b   Segal, Fábio ^c   Leistner Segal, Sandra ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Institute of the Digestive Tract (Instituto Do Aparelho Digestivo IAD)   (Brazil)

Author keywords

Esophagus; p53; Polymorphism

Indexed keywords

EID: 34548219479     PISSN: 18717934     EISSN: 18717942     Source Type: Journal    
DOI: 10.1007/s11568-007-9007-4     Document Type: Article

References (39)

1. Akar N, Akar E, Cyn P (1999) p53 genes polymorphism in the Turkish population. Turk L Hematol 16(4):187-189
2. Aldulaimi D, Jankowski J (1999) Barrett's esophagus: an overview of the molecular biology. Dis Esophagus 12:177-180
3. Audrézet MP, Robaszkiewicz M, Mercier B, Nousbaum JB, Hardy E, Bail JP, Volant A, Lozac'h P, Gouérou H, Férec C (1996) Molecular analysis of the TP53 gene in Barrett's Adenocarcinoma. Hum Mutat 7:109-113
4. Baccouche S, Mabrouk I, Said S, Mosbah A, Jlidi R, Gargouri A (2003) A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene. Cancer Lett 189:91-96
5. Blount PL, Rabinovitch PS, Haggitt RC, Reid BJ (1990) Barrett́s adenocarcinoma arises within a single aneuploid population. Gastroenterology 98:A273
6. Brenna SMF, Silva IDCG, Zeferino LC, Prereira JS, Martinez EZ, Syrjänen KJ (2004) Prognostica value of p53 codon 72 polymorphism in invasive cervical cancer in Brazil. Gynecol Oncol 93:374-380
7. Campomenosi P, Conio M, Bogliolo M, Urbini S, Assereto P, Aprile A et al (1996) p53 is frequently mutated in Barrett́s metaplasia of intestinal type. Cancer Epidemiol Biomarkers Prev 5:559-565
8. Chumakov PM, Jenkins JR (1991) BstNI/NciI polymorphism of the human p53 gene (TP53). Nucleic Acids Res 19(24):6969
9. Doak SH, Jenkins GJS, Parry EM, Griffiths AP, Shah V, Baxter JN et al (2003) Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Br J Cancer 89:1729-1735
10. Donehower LA, Bradley A (1993) The tumor suppressor p53. Biochim Biophys Acta 1155:181-205
11. Fitzgerald RC (2005) Genetics and prevention of oesophageal adenocarcinoma. Recent Results Cancer Res 166:35-46
12. Gottschlich S, Maune S, Preugschat J, Hoffmann M, Werner JA, Maass JD, Gorogh T, Heidorn K, Rudert H (2000) p53 analysis of laryngeal cancer in exon 4 to 9. Anticancer Res 20(4):2613-2616
13. Hu N, Roth MJ, Emmert-Buck MR, Tang Z, Polymeropous MQ, Goldstein AM, Han X, Dawsey SM, Ding T, Giffen C, Taylor PR (1999) Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinaltract cancer. Clin Cancer Res 5:3476-3482
14. IARC - International Agency for Research no Cancer - TP53 Mutation Database. Available at: http://www.iarc.fr/p53/index.html Cited at September 2007
15. Kawaguchi H, Ohno S, Araki K, Miyzaki M, Saeki H, Watanabe M, Tanaka S, Sugimachi K (2000) p53 Polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 60:2753-2755
16. Lacerda LL, Serrano SV, Mathes A, Rey JA, Bello MJ, Casartelli C (2005) An intronic variant in the TP53 gene in a Brazilian woman with breast cancer. Cancer Genet Cytogenet 160:160-163
17. Leistner-Segal S, Pilger DA, Kaspary APB, Lopez P, Segal F (2006) The p53 gene R72P polymorphism analysis in patients with Barrett́s Esophagus compared to normal controls. Cancer Genet Cytogenet 170:76-77
18. Li LY, Tang JT, Jia LQ, Li PW (2005) Mutations of p53 gene exons 4-8 in human esophageal cancer. World J Gastroenterol 11(19):2998-3001
19. Malcolm EK, Baber GB, Boyd James C, Stoler MH (2000) Polymorphism at codon 72 of p53 is not associated with cervical cancer risk. Mod Pathol. 13(4):373-378
20. Mazars GR, Jeanteur P, Lynch HT, Lenoir G, Theillet C (1992) Necleotide sequence polymorphirsm in a hotspot mutation region of the p53 gene. Oncogene 7(4):781-782
21. Miller SA, Dikes DD, Polensky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nuclei Acids Res 16(7): 1215
22. Nakano Y, Naoe T, Kiyoi H, Kunishima S, Minami S, Miyawaki S, Asou N, Kuriyama K., Saito H, Ohno R (2000) Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia. Leuk Res 24(4):349-352
23. NCI - National Cancer Institute. http://snp500cancer.nci.nih.gov/snp.cfm, Cited at September, 2007
24. Neshat K, Sanchez CA, Galipeau PC (1994) Barrett́s esophagus: a model of human neoplastic progression. Cold Spring Harb Symp Quant Biol 59:577-583
25. Olschwang S, Laurent-Puig P, Vassal A, Salmon R, Thomas G (1991) Characterization of a frequent polymorphism in the coding sequence of the TP53 gene in colonic cancer patients and a control population. Hum Genet 86:369-370
26. Peller S, Kolipova Y, Slutzki S, Halevy A, Kvitko K, Rotter V (1995) A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA Cell Biol 14(12):983-990
27. Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ (1999) P53-mutant clones and field effects in Barrett́s Esophagus. Cancer Res 59:4784-4787
28. Rabinovitch PS, Reid BJ, Haggitt RC, Norwood TH, Rubin CE (1989) Progression to cancer in Barrett́s esophagus is associated with genomis instability. Lab Invest 60:65-71
29. Reid B, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine DS et al (2001) Predictors of progression in Barrett́s Esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 96(10):2839-2848
30. Reid BJ, Blount PL, Rubin CE, Levine CS, Haggitt RC, Rabinovitch PS (1992) Flow-cytometry and histological progression to malignancy in Barrett́s esophagus: prospective endoscipic surveillance of a cohort. Gastroenterology 102:1212-1219
31. Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS (1987) Barrett́s esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93:1-11
32. Rocha AP (2005) Avaliação de polimorfismos no proto-oncogene Ret em pacientes com carcinoma medular de tireóide. Universidade Federal do Rio Grande do Sul, Porto Alegre
33. Segal F, Kaspary APB, Prolla JC, Leistner S (2004) p53 overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barrett́s Esophagus. Cancer Lett 210:213-218
34. Shaheen N, Ransohoff D (2002) Gastroesophageal reflux, Barrett́s Esophagus and esophageal cancer. JAMA 287(15):1972-1981
35. Soulitzis N, Sourvinos G, Dokianakis DN, Spandios DA (2002) P53 codon 72 polymorphism and association with bladder cancer. Cancer Lett 179:175-183
36. Soussi T (1996) The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 2(1):32-37
37. Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A, Ponte JF (2002) Loss of heterozygosity as a predictor to map tumor supressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol 14:65-72
38. Vos M, Adams CH, Victor TC, van Helden PD (2003) Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 140:20-30
39. NCBI - National Center for Biotechnology Information, NIH - National Institutes of Health, www.ncbi.nlm.nih.gov. Cited at 02 Apr 2007